THERAPTOSIS
Theraptosis is a biopharmaceutical company that designs and develops various drugs for cancer and neurodegenerative diseases. It also offers research and development programs covering anti-angiogenesis, targeted tumor cell killing, auto-immunity, and neuroprotection. Theraptosis was founded in 2001 and is based in Romainville, France.
THERAPTOSIS
Industry:
Biotechnology Medical Neuroscience Therapeutics
Founded:
2001-01-01
Address:
Romainville, Ile-de-France, France
Country:
France
Total Employee:
1+
Status:
Active
Total Funding:
8.4 M EUR
Similar Organizations
Janssen Belgium
Janssen Belgium is a pharmaceutical company providing medicines for an array of health concerns in several therapeutic areas.
MeSCue-Janusys
Mescue Jenasis Co., Ltd. is a biotech company that responds to unmet medical needs for periodontal diseases and neurodegenerative diseases.
Mikrobiomik
Mikrobiomik is a biopharmaceutical company that provides innovative solutions for chronic diseases.
orphanix
Orphanix is ​​a virtual pharmaceutical start-up that develops drug therapies for neglected and rare diseases called orphan diseases.
Scil Proteins
Scil Proteins, a biopharmaceutical company, discovers and develops Affilin molecules for manufacturing protein therapeutics and diagnostics.
Investors List
Auriga Partners
Auriga Partners investment in Series B - Theraptosis